BRD2 and depressive symptom measurement: Since the synaptic plasticity impairment has been proven to be a vital pathological manifestation of depression (Duman et al., 2016; Duman and Aghajanian, 2012; Holmes et al., 2019), we tested the synaptic plasticity of FSH-treated mice by a variety of experimental techniques.